BioCentury
ARTICLE | Company News

Biogazelle, Isis Pharmaceuticals deal

November 16, 2015 8:00 AM UTC

Biogazelle partnered exclusively with Isis to identify and validate targets to treat colon, liver and lung cancer. Isis will provide access to its antisense platform to Biogazelle for large-scale vali...